Oprozomib
Oprozomib (ONX-0912; PR-047) is a potent, orally bioavailable proteasome inhibitor that inhibits chymotrypsin-like (CT-L) activity of 20S proteasome β5/LMP7 with IC50 of 36/82 nM.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
532.6092
Molecular Formula
C25H32N4O7S
Notes
Research use only, not for human use.
Receptor
20Sproteasome
CAS Number
935888-69-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
